AP2005003238A0 - Novel benzoimidazole derivatives useful as antiproliferative agents. - Google Patents

Novel benzoimidazole derivatives useful as antiproliferative agents.

Info

Publication number: AP2005003238A0
Authority: AP; ARIPO
Prior art keywords: derivatives useful; antiproliferative agents; benzoimidazole derivatives; novel benzoimidazole; novel
Prior art date: 2002-08-26

Application number

AP2005003238A

Other languages

English (en)

Inventor

John Charles Kath

Joseph Peter Lyssikatos

Huifen Faye Wang

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-26

Filing date

2003-08-14

Publication date

2005-03-31

2003-08-14 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-03-31 Publication of AP2005003238A0 publication Critical patent/AP2005003238A0/xx

Links

HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical class C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
230000001028 anti-proliverative effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Toxicology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AP2005003238A 2002-08-26 2003-08-14 Novel benzoimidazole derivatives useful as antiproliferative agents. AP2005003238A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US40596902P	2002-08-26	2002-08-26
PCT/IB2003/003633 WO2004017990A1 (en)	2002-08-26	2003-08-14	Vaccine for respiratory and reproductive system infections in cattle

Publications (1)

Publication Number	Publication Date
AP2005003238A0 true AP2005003238A0 (en)	2005-03-31

Family

ID=31946951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2005003238A AP2005003238A0 (en)	2002-08-26	2003-08-14	Novel benzoimidazole derivatives useful as antiproliferative agents.

Country Status (31)

Country	Link
US (4)	US20040081666A1 (sr)
EP (2)	EP1743652B1 (sr)
JP (4)	JP2006501237A (sr)
KR (2)	KR20050062542A (sr)
CN (1)	CN1315534C (sr)
AP (1)	AP2005003238A0 (sr)
AR (1)	AR041047A1 (sr)
AT (1)	ATE533506T1 (sr)
AU (2)	AU2003263390B2 (sr)
BR (1)	BR0313806A (sr)
CA (1)	CA2496750C (sr)
EA (1)	EA011578B1 (sr)
GT (1)	GT200300180A (sr)
HR (2)	HRP20050192B1 (sr)
IS (1)	IS7672A (sr)
MA (1)	MA27388A1 (sr)
ME (1)	ME00810B (sr)
MX (1)	MXPA05002255A (sr)
NO (1)	NO20050603L (sr)
NZ (2)	NZ538394A (sr)
OA (1)	OA12915A (sr)
PA (1)	PA8581101A1 (sr)
PE (1)	PE20040420A1 (sr)
PL (1)	PL216541B1 (sr)
RS (1)	RS20050177A (sr)
TN (1)	TNSN05059A1 (sr)
TW (1)	TWI272105B (sr)
UA (1)	UA94689C2 (sr)
UY (1)	UY27948A1 (sr)
WO (1)	WO2004017990A1 (sr)
ZA (1)	ZA200501171B (sr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7179473B2 (en)	1998-06-05	2007-02-20	Boehringer Ingelheim Vetmedica Gmbh	Attenuated pestiviruses
US7135561B2 (en)	2001-09-06	2006-11-14	Boehringer Ingelheim Vetmedica Gmbh	Infectious bovine viral diarrhea virus clone
NZ538394A (en) *	2002-08-26	2008-06-30	Pfizer Prod Inc	Vaccine for respiratory and reproductive system infections in cattles
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
US7563449B2 (en) *	2003-04-21	2009-07-21	Pfizer Inc,	Methods for reducing cattle reproductive diseases
US7361357B2 (en)	2003-07-29	2008-04-22	Pfizer Inc.	Safe mutant viral vaccines
BRPI0417672A (pt) *	2003-12-17	2007-03-20	Wyeth Corp	processos para produzir composições de vìrus estáveis em armazenamento, composições de vìrus e imunogênicas
JP5393978B2 (ja) *	2004-04-05	2014-01-22	ゾエティス・ピー・エルエルシー	マイクロ流動化された水中油型乳剤及びワクチン組成物
US7572455B2 (en) *	2004-05-19	2009-08-11	Boehringer Ingelheim Vetmedica Gmbh	Vaccine comprising an attenuated pestivirus
UY29915A1 (es) *	2005-11-15	2007-06-29	Boehringer Ingelheim Vetmed	Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
SI2066340T1 (sl)	2006-09-11	2013-11-29	Zoetis P Llc	Toplotno obdelani bakterini in emulzijska cepiva, pripravljena iz takih toplotno obdelanih bakterinov
WO2008036747A2 (en) *	2006-09-21	2008-03-27	Amarillo Biosciences, Inc.	Composition and method for immunomodulation
US7803527B2 (en) *	2007-10-31	2010-09-28	Novartis Ag	Inactivated bovine herpes virus-1 and methods
RU2440137C1 (ru) *	2007-12-21	2012-01-20	Пфайзер Инк.	Термообработанные бактерины и эмульсионные вакцины, полученные из таких термообработанных бактеринов
UY31930A (es) *	2008-06-25	2010-01-29	Boheringer Ingelheim Pharma Kg	Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
BRPI0920800A2 (pt)	2008-10-03	2020-08-11	Novartis Ag	vírus da herpes bovina-1, composição, método para produzir uma resposta imunológica em um hospedeiro, e, uso de vírus da herpes bovina-1.
US8846054B2 (en) *	2009-01-09	2014-09-30	Boehringer Ingelheim Vetmedica, Inc.	Method of treating pregnant cows and/or heifers
RU2395299C1 (ru) *	2009-03-31	2010-07-27	Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ")	Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи, рота-, коронавирусной болезней и лептоспироза крупного рогатого скота
RU2395297C1 (ru) *	2009-03-31	2010-07-27	Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ")	Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи и лептоспироза крупного рогатого скота
MX345704B (es) *	2011-06-10	2017-02-10	Novartis Tiergesundheit Ag	Vacuna bovinas y métodos.
RU2522780C2 (ru) *	2012-07-27	2014-07-20	Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии Российской академии сельскохозяйственных наук	Способ получения вакцины против инфекционного ринотрахеита крупного рогатого скота
US9314519B2 (en)	2012-08-21	2016-04-19	Intervet Inc.	Liquid stable virus vaccines
US20140147475A1 (en)	2012-11-29	2014-05-29	Antonius Arnoldus Christiaan Jacobs	Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
US9393298B2 (en)	2013-03-15	2016-07-19	Intervet Inc.	Liquid stable bovine virus vaccines
US9480739B2 (en) *	2013-03-15	2016-11-01	Intervet Inc.	Bovine virus vaccines that are liquid stable
HUE048344T2 (hu)	2013-03-18	2020-08-28	Intervet Int Bv	Vakcina kérõdzõ védelmére Mannheimia haemolytica okozta tüdõgyulladás ellen
AR097762A1 (es)	2013-09-27	2016-04-13	Intervet Int Bv	Formulaciones secas de vacunas que son estables a temperatura ambiente
AR099470A1 (es)	2014-02-17	2016-07-27	Intervet Int Bv	Vacunas de virus de aves de corral líquidas
TWI670085B (zh)	2014-02-19	2019-09-01	荷蘭商英特威國際公司	液體穩定之豬病毒疫苗
CA3010977A1 (en)	2016-01-11	2017-07-20	Zoetis Services Llc	Novel cross protective vaccine compositions for porcine epidemic diarrhea virus
WO2017165366A1 (en)	2016-03-21	2017-09-28	South Dakota Board Of Regents	Orf virus-based platform for vaccine delivery
CA3037544C (en)	2016-10-05	2021-10-12	Zoetis Services Llc	Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
RU2643335C1 (ru) *	2016-11-14	2018-01-31	Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургская государственная академия ветеринарной медицины (ФГБОУ ВПО СПбГ АВМ)	Инактивированная бивалентная гидроокись алюминиевая вакцина против кампилобактериоза собак
GB201703529D0 (en)	2017-03-06	2017-04-19	Cambridge Entpr Ltd	Vaccine composition
CN110317749B (zh) *	2019-06-19	2021-01-22	山东省农业科学院奶牛研究中心	一株牛支原体强毒株及其应用
RU2764220C1 (ru) *	2020-12-02	2022-01-14	Федеральное государственное бюджетное научное учреждение "Краснодарский научный центр по зоотехнии и ветеринарии" ФГБНУ КНЦЗВ	Способ предупреждения риска заболевания парагриппом-3 у телят

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3634587A (en) *	1969-11-06	1972-01-11	Ralston Purina Co	Method of immunizing cattle against bovine respiratory disease syndrome
BE759425A (fr) *	1969-11-28	1971-05-25	Mebus Charles A	Vaccins contre la diarrhee du veau, leur preparation et emploi
US5593873A (en)	1986-01-27	1997-01-14	Syntro Corporation	Recombinant infectious bovine rhinotracheitis virus
US5084269A (en)	1986-11-06	1992-01-28	Kullenberg Fred W	Adjuvant for dose treatment with antigens
EP0273512B1 (en)	1986-12-19	1991-02-27	Duphar International Research B.V	Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
US6291228B1 (en) *	1988-08-03	2001-09-18	Vericore Limited	Vaccine
GB8818415D0 (en) *	1988-08-03	1988-09-07	Animal Health Inst	Vaccine
MX9301736A (es)	1992-03-30	1994-01-31	Smithkline Beecham Corp	Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
US5951988A (en) *	1993-03-30	1999-09-14	University Of Saskatchewan	Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
NZ276234A (en)	1993-11-05	1998-01-26	Bayer Ag Substituted Under Sec	An attenuated replicating non pathogenic flavivirus (bovine viral diarrhoea virus - bvdv) vaccine
WO1995030437A1 (en) *	1994-05-10	1995-11-16	American Home Products Corporation	Improved modified live brsv vaccine
US5709865A (en)	1994-11-10	1998-01-20	Biostar Inc.	Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en)	1996-05-24	1999-12-14	Board Of Regents Of University Of Nebraska	Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6060457A (en)	1996-06-20	2000-05-09	Universite De Montreal	DNA plasmid vaccine for immunization of animals against BVDV
BR9803232A (pt) *	1997-08-26	2000-01-11	Pfizer Prod Inc	Vaicna de neospora.
AU1145699A (en) *	1997-09-05	1999-03-22	Smithkline Beecham Biologicals (Sa)	Oil in water emulsions containing saponins
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
EP0924295A3 (en) *	1997-12-04	2001-05-16	Pfizer Products Inc.	DNA encoding neospora dihydrofolate reductase-thymidylate synthase
EP1071454A1 (en)	1998-04-24	2001-01-31	Washington University	Chimeras of hepatitis c virus and bovine viral diarrhea virus
AU769539B2 (en) *	1999-01-29	2004-01-29	Zoetis Services Llc	Adjuvants for use in vaccines
NZ538394A (en) *	2002-08-26	2008-06-30	Pfizer Prod Inc	Vaccine for respiratory and reproductive system infections in cattles
ATE512660T1 (de)	2007-03-05	2011-07-15	Cadila Healthcare Ltd	Zusammensetzungen mit peg-interferon-alpha- konjugaten und raffinose als kryoschutzmittel

2003
- 2003-08-14 NZ NZ538394A patent/NZ538394A/en not_active IP Right Cessation
- 2003-08-14 WO PCT/IB2003/003633 patent/WO2004017990A1/en not_active Ceased
- 2003-08-14 OA OA1200500058A patent/OA12915A/en unknown
- 2003-08-14 BR BR0313806-2A patent/BR0313806A/pt not_active Application Discontinuation
- 2003-08-14 NZ NZ565206A patent/NZ565206A/en not_active IP Right Cessation
- 2003-08-14 PL PL375548A patent/PL216541B1/pl unknown
- 2003-08-14 AT AT06122758T patent/ATE533506T1/de active
- 2003-08-14 MX MXPA05002255A patent/MXPA05002255A/es active IP Right Grant
- 2003-08-14 EP EP06122758A patent/EP1743652B1/en not_active Expired - Lifetime
- 2003-08-14 JP JP2004530459A patent/JP2006501237A/ja active Pending
- 2003-08-14 EA EA200500275A patent/EA011578B1/ru not_active IP Right Cessation
- 2003-08-14 AP AP2005003238A patent/AP2005003238A0/xx unknown
- 2003-08-14 HR HRP20050192AA patent/HRP20050192B1/hr not_active IP Right Cessation
- 2003-08-14 KR KR1020057003230A patent/KR20050062542A/ko not_active Ceased
- 2003-08-14 CN CNB038203162A patent/CN1315534C/zh not_active Expired - Lifetime
- 2003-08-14 AU AU2003263390A patent/AU2003263390B2/en not_active Expired
- 2003-08-14 UA UAA200501771A patent/UA94689C2/ru unknown
- 2003-08-14 HR HR20090271A patent/HRP20090271A2/xx not_active Application Discontinuation
- 2003-08-14 KR KR1020067022893A patent/KR20060116037A/ko not_active Ceased
- 2003-08-14 RS YUP-2005/0177A patent/RS20050177A/sr unknown
- 2003-08-14 CA CA2496750A patent/CA2496750C/en not_active Expired - Lifetime
- 2003-08-14 ME MEP-2009-213A patent/ME00810B/me unknown
- 2003-08-14 EP EP03792580A patent/EP1536830A1/en not_active Ceased
- 2003-08-20 TW TW092122872A patent/TWI272105B/zh not_active IP Right Cessation
- 2003-08-22 UY UY27948A patent/UY27948A1/es not_active Application Discontinuation
- 2003-08-22 PE PE2003000857A patent/PE20040420A1/es not_active Application Discontinuation
- 2003-08-25 AR ARP030103054A patent/AR041047A1/es unknown
- 2003-08-25 GT GT200300180A patent/GT200300180A/es unknown
- 2003-08-25 PA PA20038581101A patent/PA8581101A1/es unknown
- 2003-08-26 US US10/647,919 patent/US20040081666A1/en not_active Abandoned
2005
- 2005-01-27 IS IS7672A patent/IS7672A/is unknown
- 2005-02-03 NO NO20050603A patent/NO20050603L/no not_active Application Discontinuation
- 2005-02-09 ZA ZA200501171A patent/ZA200501171B/en unknown
- 2005-02-25 TN TNP2005000059A patent/TNSN05059A1/fr unknown
- 2005-02-25 MA MA28121A patent/MA27388A1/fr unknown
2007
- 2007-08-30 US US11/897,421 patent/US20070298053A1/en not_active Abandoned
2008
- 2008-12-16 AU AU2008258154A patent/AU2008258154B2/en not_active Expired
2009
- 2009-05-15 JP JP2009118662A patent/JP2009215309A/ja not_active Withdrawn
2010
- 2010-06-22 US US12/820,566 patent/US9662384B2/en active Active
2011
- 2011-12-16 JP JP2011275303A patent/JP5785073B2/ja not_active Expired - Lifetime
2012
- 2012-12-28 US US13/729,206 patent/US20130129779A1/en not_active Abandoned
2015
- 2015-06-03 JP JP2015113008A patent/JP2015172069A/ja active Pending

Also Published As

Publication number	Publication date
KR20050062542A (ko)	2005-06-23
US20040081666A1 (en)	2004-04-29
NZ565206A (en)	2008-12-24
AR041047A1 (es)	2005-04-27
ME00810B (me)	2012-03-20
IS7672A (is)	2005-01-27
ATE533506T1 (de)	2011-12-15
MA27388A1 (fr)	2005-06-01
CN1678346A (zh)	2005-10-05
PA8581101A1 (es)	2005-11-25
UA94689C2 (ru)	2011-06-10
NO20050603L (no)	2005-03-17
JP5785073B2 (ja)	2015-09-24
EA011578B1 (ru)	2009-04-28
OA12915A (en)	2006-10-13
EP1536830A1 (en)	2005-06-08
AU2003263390A1 (en)	2004-03-11
UY27948A1 (es)	2004-03-31
HRP20050192A2 (en)	2005-06-30
HK1078457A1 (en)	2006-03-17
TNSN05059A1 (fr)	2007-05-14
EP1743652B1 (en)	2011-11-16
AU2008258154A1 (en)	2009-01-08
PL216541B1 (pl)	2014-04-30
PE20040420A1 (es)	2004-07-24
CA2496750C (en)	2014-10-21
WO2004017990A1 (en)	2004-03-04
TW200404565A (en)	2004-04-01
US20070298053A1 (en)	2007-12-27
JP2015172069A (ja)	2015-10-01
JP2009215309A (ja)	2009-09-24
HRP20090271A2 (en)	2009-11-30
PL375548A1 (en)	2005-11-28
NZ538394A (en)	2008-06-30
GT200300180A (es)	2004-05-18
AU2008258154B2 (en)	2011-07-21
KR20060116037A (ko)	2006-11-13
ZA200501171B (en)	2006-12-27
AU2003263390B2 (en)	2008-12-18
EP1743652A1 (en)	2007-01-17
JP2012092126A (ja)	2012-05-17
TWI272105B (en)	2007-02-01
US9662384B2 (en)	2017-05-30
EA200500275A1 (ru)	2005-08-25
CA2496750A1 (en)	2004-03-04
CN1315534C (zh)	2007-05-16
JP2006501237A (ja)	2006-01-12
US20130129779A1 (en)	2013-05-23
HRP20050192B1 (hr)	2014-02-14
MXPA05002255A (es)	2005-06-08
US20100266629A1 (en)	2010-10-21
BR0313806A (pt)	2005-07-05
RS20050177A (sr)	2007-06-04

Publication	Publication Date	Title
PL377678A1 (pl)	2006-02-06	Nowe pochodne benzoimidazolu stosowane jako środki antyproliferacyjne
SI1555267T1 (sl)	2013-05-31	2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI
MXPA03000966A (es)	2003-09-04	Agentes antidiabeticos.
IL174533A0 (en)	2006-08-01	Quinazoline derivatives as antiproliferative agents
PL371922A1 (en)	2005-07-11	Aza-arylpiperazines
IL163652A0 (en)	2005-12-18	Substituted hydroxyethylamines
AU2003202091A8 (en)	2003-06-10	Guanidine derivatives
PL372307A1 (en)	2005-07-11	Substituted 4-aminocyclohexanols
AU2003290818A8 (en)	2004-06-03	Topoisomerase-targeting agents
IL166740A0 (en)	2006-01-15	Substituted heterocyclylpyrimidines
IL163790A0 (en)	2005-12-18	5-Substituted-alkylaminopyrazole derivatives as pesticides
DE60326941D1 (en)	2009-05-14	Rs
GB0229662D0 (en)	2003-01-29	Nanostructures
PL377325A1 (pl)	2006-01-23	Podstawione benzodioksepiny
GB0210260D0 (en)	2002-06-12	Pesticides
GB0218269D0 (en)	2002-09-11	Disinfectants
GB0202011D0 (en)	2002-03-13	The Fucker
GB0212491D0 (en)	2002-07-10	The gripper
AU2822P (en)	2005-07-29	Edelblau Plectranthus saccatus x Plectranthus hilliardiae
ZA200308674B (en)	2004-07-12	Jigging.
GB0215788D0 (en)	2002-08-14	Nanostructures
GB0204798D0 (en)	2002-04-17	Cycostatic agents
GB0218699D0 (en)	2002-09-18	Animal spooker
GB0221853D0 (en)	2002-10-30	Animal scarer
GB0212807D0 (en)	2002-07-10	Floodgate